Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation

Details for Australian Patent Application No. 2005321609 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Weichsel, Aleksandra; Dedio, Juergen; Shimshock, Stephen; Grueneberg, Sven; Kosley, Raymond W.; Lanter, Carolina; Li, Hui; Knieps, Stephanie; Sher, Rosy; Czechtizky, Werngard; Heitsch, Holger

Agent Watermark

Pub. Number AU-B-2005321609

PCT Pub. Number WO2006/069656

Priority 04031009.6 30.12.04 EP

Filing date 17 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 17 February 2011

International Classifications

C07C 235/66 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 207/32 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/68 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/69 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/14 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 249/06 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 249/18 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 271/12 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 277/64 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 319/20 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/069656 Priority application(s): WO2006/069656

17 February 2011 Application Accepted

  Published as AU-B-2005321609

16 June 2011 Standard Patent Sealed

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321611-Method for producing pure or enriched Q 10 coenzyme

2005321608-Synergistic mixtures exhibiting insecticidal and fungicidal action